Cohesys will now be listed on Alto’s marketplace, giving investors the opportunity to invest in the company in its early stages, according to a June 11 press release.
For a minimum investment of $10,000, Alto members can invest in Cohesys and its product, BoneTape, while the company navigates clinical trials and early customer adoption.
